Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This week symbols : Alpmf save search
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
TAK | News | $13.245 -1.01% 680K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
granted approval cancer treatment for
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Published: 2024-04-22 (Crawled : 09:00) - prnewswire.com
SMFNF | News | $55.63 24K
|
Finance
|
| O: -0.16%
H: 3.14%
C: 0.04%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: 0.63%
H: 0.0%
C: -0.31%
TAK | News | $13.245 -1.01% 680K
|
Health Technology
|
| O: 0.8%
H: 0.75%
C: 0.38%
drug company for agreement
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.